Alternatives to Shapely

The lowest advertised flat rate we checked this pass — $79/mo semaglutide, $129/mo tirzepatide, plus an unusual oral gum option — but the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held, and you pay before the eligibility consult happens.

• $20/mo cheaper than Shapely
• serves all 50 states, where Shapely lists Not published on the site

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• serves all 50 states, where Shapely lists Not published on the site
• scores 76/100 against Shapely's 50

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• serves all 50 states, where Shapely lists Not published on the site
• scores 76/100 against Shapely's 50

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

• serves all 50 states, where Shapely lists Not published on the site
• scores 89/100 against Shapely's 50

The price-first pick: some of the lowest flat, all-inclusive compounded pricing we track, nationwide — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

• serves all 50 states, where Shapely lists Not published on the site
• scores 80/100 against Shapely's 50

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

• serves all 50 states, where Shapely lists Not published on the site
• scores 78/100 against Shapely's 50

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.

• $20/mo cheaper than Shapely
• serves all 50 states, where Shapely lists Not published on the site

Lean Meds sells one all-inclusive membership per molecule — the telehealth visit, the care plan, the medication and shipping in a single monthly charge, at the same price whatever dose you end up on — and it publishes the whole price ladder on the homepage before you answer a single question. That is the good part, and the flat-by-dose promise matters more than the sticker: providers that charge by dose routinely double between a starting dose and a maintenance dose, and this one does not. The sticker itself needs reading carefully, because the $69 the homepage headlines under a countdown timer is the twelve-month tier; month to month it is $79 for compounded semaglutide and $109 for compounded tirzepatide, with $76/$105 at three months and $73/$100 at six. Two things temper it. The clinical and pharmacy layers are thin on names — clinicians come from the OpenLoop network, fills go to unnamed 503A pharmacies 'within the Lean Meds pharmacy network,' and no individual pharmacy or clinician appears anywhere. And the operator named throughout its own Terms, Trinity HealthCare Supply, LLC, is the company FDA wrote to on 8 June 2026 under its other brand, altRx, for putting its own name on vials it did not compound and calling compounded GLP-1s 'clinically proven.' That letter is about altrx.com, not this site — but it is the same legal entity at the same Miami suite, and a search for 'Lean Meds' alone would never surface it.

• $20/mo cheaper than Shapely
• serves all 50 states, where Shapely lists Not published on the site

LegitScript-certified and licensed in all 50 states, with GLP-1 treatments starting at $89/month (all-inclusive: consult, medication, clinical support, free shipping) — but the homepage hero banner separately advertises '$99 first month' for the same program, an unresolved on-site inconsistency, and tirzepatide is offered in the nav with no price disclosed anywhere. Maves operates under parent brand Homera Health, disclosed via its own footer and login links rather than hidden, and the site charges no separate membership fee on top of the treatment price — but it also publishes no cancellation or refund policy anywhere a reader can check before paying, which is a real gap for a program billed monthly.

• $10/mo cheaper than Shapely
• serves all 50 states, where Shapely lists Not published on the site